Abstract
Retinopathy of prematurity (ROP) is a proliferative vitreoretinopathy affecting premature infants which a leading cause of childhood blindness worldwide. Screening is scheduled according to gestational age and birth weight to detect ROP development and to determine the appropriate timing of treatment. Screening also identified any risk factors for ROP development. Aim of this study is to evaluate risk factors, choice of treatment and outcome based on severity of ROP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
